Società Charles River Laboratories International, Inc.

CRL

US1598641074

Biotecnologia

Consensus Analisti

Attività

Vendite per attività

Vendite per regione

Dirigenti

Amministratori

Classe di azioni

Azionisti

Coordinate società

Società del gruppo

Settore

Vendite per attività

Vendite per regione

Rating per Charles River Laboratories International, Inc.

Revisioni EPS

Utili trimestrali - Indice di sorpresa

Settore Biotecnologia e ricerca medica - Altri

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Mercato chiuso - Nyse Altri mercati azionari 22:00:02 26/04/2024			Variaz. 5gg	Var. 1 gen.
229 ^USD	+0,54%		+0,99%	-3,12%

25/04	FibroBiologics, Inc. prevede di collaborare con Charles River Laboratories per produrre sferoidi a base di fibroblasti	CI
24/04	Charles River Laboratories deposita un supplemento alla dichiarazione definitiva di delega presso la Securities and Exchange Commission	CI

Charles River Laboratories International, Inc. è specializzata nello sviluppo di prodotti e servizi nel campo della ricerca e dello sviluppo di farmaci non clinici per aziende farmaceutiche, agenzie governative e istituzioni accademiche. Le vendite nette sono suddivise per attività come segue:
- servizi di scoperta e valutazione della sicurezza (63,4%): servizi di scoperta per l'identificazione, lo screening e la selezione dei composti principali per lo sviluppo di nuovi candidati farmaci, e test in vivo e in vitro, compresi studi farmacocinetici, bioanalitici, metabolici, tossicologici e patologici, per la valutazione della sicurezza di prodotti farmaceutici, dispositivi medici, prodotti per la salute animale, prodotti chimici e agrochimici e biocidi;
- sviluppo e vendita di modelli di ricerca e servizi correlati (19,2%): topi, ratti, modelli immunodeficienti, conigli, cavie, criceti, ecc. Il Gruppo offre anche cellule primarie e prodotti specializzati (prodotti per la bioconservazione, terreni di congelamento per le colture cellulari, antigeni, peptidi, modelli di topi umanizzati, ecc;
- sviluppo di soluzioni utilizzate nei processi di produzione di farmaci (17,5%): prodotti e servizi per test microbiologici, test in vitro, test di endotossina, identificazione microbica, sviluppo, produzione di vaccini aviari, ecc. Il gruppo offre anche servizi di produzione a contratto per terapie cellulari e geniche.
Le vendite nette si suddividono per fonte di reddito tra vendite di servizi (83,3%) e vendite di prodotti (16,7%).
Le vendite nette sono distribuite geograficamente come segue: Stati Uniti (56,8%), Europa (26%), Canada (11,8%), Asia/Pacifico (4,9%) e altro (0,4%).

Numero di dipendenti: 21 100

USD in Milioni	2022	Peso	2023	Peso	Delta
Discovery and Safety Assessment 63,3 %	2 447	61,6 %	2 616	63,3 %	+6,88%
Research Models and Services 19,2 %	739	18,6 %	792	19,2 %	+7,19%
Manufacturing Solutions 17,5 %	790	19,9 %	721	17,5 %	-8,63%

USD in Milioni	2022	Peso	2023	Peso	Delta
United States 56,8 %	2 342	58,9 %	2 347	56,8 %	+0,23%
Europe 26,1 %	1 032	26,0 %	1 077	26,1 %	+4,34%
Canada 11,8 %	399	10,0 %	487	11,8 %	+22,14%
Asia Pacific 4,9 %	193	4,8 %	201	4,9 %	+4,15%
Other 0,4 %	10	0,3 %	17	0,4 %	+69,19%

Dirigenti	Titolo	Età	Da
James Foster CEO	Chief Executive Officer	73	01/01/76
Flavia Pease DFI	Director of Finance/CFO	51	25/04/22
Birgit Girshick COO	Chief Operating Officer	54	01/04/89
Julie Frearson CTO	Chief Tech/Sci/R&D Officer	-	01/01/14
Mark Mintz CTO	Chief Tech/Sci/R&D Officer	-	01/02/21
Barbara Patterson CMP	Compliance Officer	-	01/02/01
Matthew Daniel CMP	Compliance Officer	-	01/01/05
Todd Spencer IRC	Investor Relations Contact	-	01/06/18
Michael Knell AUD	Comptroller/Controller/Auditor	47	26/04/17
John C. Ho PRN	Corporate Officer/Principal	64	01/01/12

Amministratori	Titolo	Età	Da
C. Reese BRD	Director/Board Member	78	03/12/07
George Massaro BRD	Director/Board Member	76	01/01/03
Virginia Wilson BRD	Director/Board Member	68	01/10/19
Robert Bertolini BRD	Director/Board Member	61	25/01/11
Deborah Kochevar BRD	Director/Board Member	67	29/10/08
Richard Wallman BRD	Director/Board Member	72	24/01/11
James Foster CEO	Chief Executive Officer	73	01/01/76
Martin MacKay BRD	Director/Board Member	68	05/07/17
Nancy Andrews BRD	Director/Board Member	65	28/02/20
George Llado BRD	Director/Board Member	58	16/10/20

	Voto	Quantità	Flottante	Autocontrollo	Flottante totale
Azione A	1	51 510 790	50 578 267 ( 98,19 %)	0	98,19 %

Nome	Azioni	%	Valorizzazione
Vanguard Fiduciary Trust Co. 11,65 %	5 980 306	11,65 %	1 620 M $
BlackRock Advisors LLC 8,690 %	4 462 372	8,690 %	1 209 M $
STATE STREET CORPORATION 4,011 %	2 059 785	4,011 %	558 M $
Kayne Anderson Rudnick Investment Management LLC 3,414 %	1 753 238	3,414 %	475 M $
ClearBridge Investments LLC 2,859 %	1 468 059	2,859 %	398 M $
T. Rowe Price International Ltd. 2,810 %	1 443 175	2,810 %	391 M $
Meritage Group LP 2,250 %	1 155 376	2,250 %	313 M $
Geode Capital Management LLC 2,232 %	1 146 009	2,232 %	311 M $
Allspring Global Investments LLC 2,179 %	1 118 816	2,179 %	303 M $
Ariel Investments LLC 2,046 %	1 050 698	2,046 %	285 M $

Charles River Laboratories International, Inc.

251 Ballardvale Street

01887, Wilmington

+781 222 6000

http://www.criver.com

Indirizzo Charles River Laboratories International, Inc.(CRL)

Nome	Categoria e settore
Charles River Laboratories, Inc. Charles River Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Charles River Laboratories, Inc. provides research models and laboratory animal support services. It offers quality research models and support services to the biomedical community. The company was founded in 1947 and is headquartered in Wilmington, MA.	Miscellaneous Commercial Services
Celsis International Ltd. Celsis International Ltd. Medical SpecialtiesHealth Technology Celsis International Ltd. develops and supplies medical diagnostic products and laboratory services. The company was founded by Sir Christopher Evans in 1992 and is headquartered in Westminster, the United Kingdom.	Medical Specialties
Charles River Discovery Research Services Finland Oy Charles River Discovery Research Services Finland Oy Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services Finland Oy provides non-clinical central nervous system services to the pharmaceutical and biotechnology industries. The company was founded in 1998 and is located in Kuopio, Finland.	Miscellaneous Commercial Services
Charles River Laboratories Japan, Inc. Charles River Laboratories Japan, Inc. Miscellaneous Commercial ServicesCommercial Services Part of The Jackson Laboratory, Charles River Laboratories Japan, Inc. provides laboratory testing and research services. The private company is based in Yokohama, Japan. The Japanese company was founded in 1972. Charles River Laboratories Japan was acquired by The Jackson Laboratory from Charles River Laboratories International, Inc. on October 12, 2021 for $0.56 million.	Miscellaneous Commercial Services
Charles River Laboratories Holdings Ltd. Charles River Laboratories Holdings Ltd. Financial ConglomeratesFinance Part of Charles River Laboratories International, Inc., Charles River Laboratories Holdings Ltd. is a British company that provides investment services. The private company is based in Margate, UK and was founded in 1999.	Financial Conglomerates
Charles River UK Ltd. Charles River UK Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 1969, Charles River UK Ltd. is a subsidiary of Charles River Laboratories International, Inc. The private company is based in Margate, UK and engages in research and experimental development on biotechnology.	Miscellaneous Commercial Services
Charles River Laboratories Preclinical Services Montreal ULC Charles River Laboratories Preclinical Services Montreal ULC Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Charles River Laboratories Preclinical Services Montreal ULC is a private company based in Senneville, Canada.	Miscellaneous Commercial Services
Charles River Nederland BV Charles River Nederland BV Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Charles River Nederland BV is a private company based in Leiden, the Netherlands.	Miscellaneous Commercial Services
Ballardvale CV
Charles River Laboratories Sain-Constant SA Charles River Laboratories Sain-Constant SA Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Charles River Laboratories Sain-Constant SA is a Canadian company that provides laboratory testing and research services. The private company is based in St.Constant, Canada.	Miscellaneous Commercial Services
Charles River Laboratories Luxembourg SARL Charles River Laboratories Luxembourg SARL Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Charles River Laboratories Luxembourg SARL is a Luxembourger company that provides laboratory testing and research services. The private company is located in Luxembourg.	Miscellaneous Commercial Services

Rating Trading

Rating Investimento

ESG Refinitiv

C+

Altri rating

Vendita

Buy

Raccomandazione media

Accumulate

Numero di analisti

Ultimo prezzo di chiusura

229 USD

Prezzo obiettivo medio

270,7 USD

Differenza / Target Medio

+18,18%

Consenso

Revisioni delle Stime

Calendario della società

Biotecnologia/Farmaceutici

Biotecnologia e ricerca medica

Biotecnologia

Biotecnologia e ricerca medica - Altri

	Variaz. 1 gen.	Capi.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3,12%	11,76 Mrd
IQVIA HOLDINGS INC.	+1,51%	42,75 Mrd
LONZA GROUP AG	+49,22%	41,61 Mrd
MODERNA, INC.	+8,57%	41,34 Mrd
CELLTRION, INC.	-12,36%	26,59 Mrd
ICON PUBLIC LIMITED COMPANY	+8,92%	25,49 Mrd
ALNYLAM PHARMACEUTICALS, INC.	-25,13%	18,12 Mrd
MEDPACE HOLDINGS, INC.	+29,17%	12,24 Mrd
UNITED THERAPEUTICS CORPORATION	+6,35%	11 Mrd
BIO-TECHNE CORPORATION	-16,98%	10,07 Mrd

Biotecnologia e ricerca medica - Altri